FDA gives HDE (humanitarian device exemption) approval for gastric stimulation system
This article was originally published in Clinica
Executive Summary
The US FDA has approved Medtronic's implantable electrical stimulation device for treating patients with a rare but severe and often life-threatening form of gastroparesis, a gastrointestinal disorder marked by chronic vomiting and nausea.
You may also be interested in...
FDA Assembling Advisors To Discuss Pediatric HDE Products
As part of a periodic review, FDA is bringing together experts to review several products that are conditionally available for pediatric use under the agency's Humanitarian Device Exemption program.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.